Vanda Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:VNDA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
14 Nov 24	SellUS$25,863	Stephen Mitchell	Individual	5,000	US$5.17
29 Jul 24	SellUS$13,327	Kevin Moran	Individual	2,251	US$5.92
05 Mar 24	SellUS$73,379	Gunther Birznieks	Individual	17,411	US$4.30
05 Mar 24	SellUS$63,393	Kevin Moran	Individual	14,700	US$4.48
05 Mar 24	SellUS$231,339	Mihael Polymeropoulos	Individual	55,172	US$4.24
05 Mar 24	SellUS$71,921	Joakim Wijkstrom	Individual	16,727	US$4.41
05 Mar 24	SellUS$73,313	Timothy Williams	Individual	17,088	US$4.41

Insider Trading Volume

Insider Buying: VNDA insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of VNDA?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,674,896	2.87%
Hedge Funds	4,011,522	6.88%
General Public	10,683,699	18.3%
Institutions	41,938,027	71.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 64.34% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.7%	BlackRock, Inc.	8,595,607	US$41.1m	5.62%	no data
6.88%	Renaissance Technologies LLC	4,011,522	US$19.2m	-2.49%	0.03%
6.23%	The Vanguard Group, Inc.	3,631,289	US$17.4m	5.82%	no data
4.04%	Tang Capital Management, LLC	2,353,307	US$11.2m	9.29%	0.82%
3.88%	Dimensional Fund Advisors LP	2,261,091	US$10.8m	12.3%	no data
3.26%	Acadian Asset Management LLC	1,900,002	US$9.1m	-4.14%	0.02%
2.73%	Nantahala Capital Management, LLC	1,593,516	US$7.6m	0%	0.57%
2.45%	Jacobs Levy Equity Management Inc	1,430,533	US$6.8m	-3.75%	0.02%
2.45%	Geode Capital Management, LLC	1,425,827	US$6.8m	7.13%	no data
2.14%	Mihael Polymeropoulos	1,249,230	US$6.0m	0%	no data
2%	State Street Global Advisors, Inc.	1,165,182	US$5.6m	-3.81%	no data
1.78%	Schroder Investment Management Limited	1,038,020	US$5.0m	-10.2%	no data
1.34%	Connor, Clark & Lunn Investment Management Ltd.	780,933	US$3.7m	7.66%	0.02%
1.23%	Federated Hermes, Inc.	716,779	US$3.4m	0.16%	0.01%
1.11%	Bridgeway Capital Management, LLC	647,774	US$3.1m	-1.06%	0.05%
1.1%	PGIM, Inc.	642,580	US$3.1m	-0.05%	no data
1.02%	Charles Schwab Investment Management, Inc.	596,210	US$2.8m	0.59%	no data
0.96%	D. E. Shaw & Co., L.P.	559,798	US$2.7m	-19.2%	no data
0.94%	Goldman Sachs Asset Management, L.P.	548,494	US$2.6m	105%	no data
0.86%	Northern Trust Global Investments	501,159	US$2.4m	2.93%	no data
0.71%	Krensavage Asset Management, LLC	414,684	US$2.0m	-37.4%	1.08%
0.69%	SEI Investments Management Corporation	401,462	US$1.9m	1.01%	no data
0.69%	Millennium Management LLC	399,510	US$1.9m	2,360%	no data
0.57%	Profit Investment Management, LLC	329,822	US$1.6m	-42.3%	1.21%
0.55%	SEI Investments Company	319,956	US$1.5m	-19%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 09:03
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vanda Pharmaceuticals Inc. is covered by 21 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Difei Yang	Aegis Capital Corporation
null null	Argus Research Company
Olivia Brayer	BofA Global Research